CinCor Pharma Current Cash

CinCor Pharma (CINC) currently reports a current cash of $290M as of September 2022. That compares with $140M in the prior-year period — up 106.5% year over year. Use the charts on this page to explore CinCor Pharma's current cash history and peer comparisons.

CinCor Pharma's current cash increased from $140M to $290M — a 106.5% year-over-year increase (period ending September 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

CinCor Pharma reported $290M in current cash as of September 2022. That compares with $140M in the prior-year period — up 106.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $290M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for CinCor Pharma, and consider following CINC for alerts when major investors trade the stock.